JP Morgan Maintains Overweight on Mobia Medical, Raises Price Target to $17
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Robbie Marcus maintains Mobia Medical (NASDAQ:MOBI) with a Overweight and raises the price target from $15 to $17.
JP Morgan analyst Robbie Marcus maintains Mobia Medical (NASDAQ:MOBI) with a Overweight and raises the price target from $15 to $17.